Phenotypic evolution of therapeutic Salmonella enterica serovartyphimurium after invasion of TRAMP mouse prostate tumor

mBio

Volumn 5, Issue 4, 2014, Pages

  Choe, Elizabeth ^a,b   Kazmierczak, Robert A ^b,c   Eisenstark, Abraham ^b,c  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b Cancer Research Center   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIAL METABOLISM; BACTERIAL STRAIN; BACTERIOPHAGE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CANCER GROWTH; CANCER SURVIVAL; CONTROLLED STUDY; ENERGY CONSUMPTION; FLAGELLUM; LIVER; MALE; MICROBIAL MORPHOLOGY; MOLECULAR EVOLUTION; MOUSE; NONHUMAN; PHENOTYPE; PHENOTYPIC EVOLUTION; PROSTATE ADENOCARCINOMA; SALMONELLA TYPHIMURIUM; SPLEEN; TRANSMISSION ELECTRON MICROSCOPY; TUMOR INVASION; WILD TYPE; ANIMAL; ANIMAL SALMONELLOSIS; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PROSTATIC NEOPLASMS; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM;

SALMONELLA ENTERICA;

ANIMALS; MALE; MICE; PROSTATIC NEOPLASMS; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM;

EID: 84908224771     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01182-14     Document Type: Article

References (33)

1. Bermudes D, Zheng LM, King IC. 2002. Live bacteria as anticancer agents and tumor-selective protein delivery vectors. Curr. Opin. Drug Discov. Dev. 5:194-199.
2. Nguyen VH, Kim HS, Ha JM, Hong Y, Choy HE, Min JJ. 2010. Genetically engineered Salmonella typhimurium as an imageable therapeutic probe for cancer. Cancer Res. 70:18-23. http://dx.doi.org/10.1158/1538-7445.AM10-18.
3. Hayashi K, Zhao M, Yamauchi K, Yamamoto N, Tsuchiya H, Tomita K, Hoffman RM. 2009. Cancer metastasis directly eradicated by targeted therapy with a modified Salmonella typhimurium. J. Cell. Biochem. 106: 992-998. http://dx.doi.org/10.1002/jcb.22078.
4. Toso JF, Gill VJ, Hwu P, Marincola FM, Restifo NP, Schwartzentruber DJ, Sherry RM, Topalian SL, Yang JC, Stock F, Freezer LJ, Morton KE, Seipp C, Haworth L, Mavroukakis S, White D, MacDonald S, Mao J, Sznol M, Rosenberg SA. 2002. Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J. Clin. Oncol. 20:142-152. http://dx.doi.org/10.1200/JCO.20.1.142.
5. Forbes NS. 2010. Engineering the perfect (bacterial) cancer therapy. Nat. Rev. Cancer 10:785-794. http://dx.doi.org/10.1038/nrc2934.
6. Pawelek JM, Low KB, Bermudes D. 1997. Tumor-targeted Salmonella as a novel anticancer vector. Cancer Res. 57:4537-4544.
7. El-Aneed A. 2004. An overview of current delivery systems in cancer gene therapy. J. Control. Release 94:1-14. http://dx.doi.org/10.1016/j.jconrel.2003.09.013.
8. Bernardes N, Chakrabarty AM, Fialho AM. 2013. Engineering of bacterial strains and their products for cancer therapy. Appl. Microbiol. Biotechnol. 97:5189-5199. http://dx.doi.org/10.1007/s00253-013-4926-6.
9. Zhao M, Suetsugu A, Ma H, Zhang L, Liu F, Zhang Y, Tran B, Hoffman RM. 2012. Efficacy against lung metastasis with a tumor-targeting mutant of Salmonella typhimurium in immunocompetent mice. Cell Cycle 11: 187-193. http://dx.doi.org/10.4161/cc.11.1.18667.
10. Vendrell A, Gravisaco MJ, Pasetti MF, Croci M, Colombo L, Rodríguez C, Mongini C, Waldner CI. 2011. A novel Salmonella Typhi-based immunotherapy promotes tumor killing via an antitumor Th1-type cellular immune response and neutrophil activation in a mouse model of breast cancer. Vaccine 29:728-736. http://dx.doi.org/10.1016/j.vaccine.2010.11.017.
11. Zhong Z, Kazmierczak RA, Dino A, Khreis R, Eisenstark A, Schatten H. 2007. Salmonella-host cell interactions, changes in host cell architecture, and destruction of prostate tumor cells with genetically altered Salmonella. Microsc. Microanal. 13:372-383. http://dx.doi.org/10.1017/S1431927607070833.
12. Budynek P, Dabrowska K, Skaradzinski G, Górski A. 2010. Bacteriophages and cancer. Arch. Microbiol. 192:315-320. http://dx.doi.org/10.1007/s00203-010-0559-7.
13. Rakhuba DV, Kolomiets EI, Dey ES, Novik GI. 2010. Bacteriophage receptors, mechanisms of phage adsorption and penetration into host cell. Pol. J. Microbiol. 59:145-155.
14. Stecher B, Hapfelmeier S, Müller C, Kremer M, Stallmach T, Hardt WD. 2004. Flagella and chemotaxis are required for efficient induction of Salmonella enterica serovar Typhimurium colitis in streptomycinpretreated mice. Infect. Immun. 72:4138-4150. http://dx.doi.org/10.1128/IAI.72.7.4138-4150.2004.
15. Sharma VK, Bearson SM, Bearson BL. 2010. Evaluation of the effects of sdiA, a luxR homologue, on adherence and motility of Escherichia coli O157:H7. Microbiology 156:1303-1312.
16. Verstraeten N, Braeken K, Debkumari B, Fauvart M, Fransaer J, Vermant J, Michiels J. 2008. Living on a surface: swarming and biofilm formation. Trends Microbiol. 16:496-506. http://dx.doi.org/10.1016/j.tim.2008.07.004.
17. Toguchi A, Siano M, Burkart M, Harshey RM. 2000. Genetics of swarming motility in Salmonella enterica serovar typhimurium: critical role for lipopolysaccharide. J. Bacteriol. 182:6308-6321. http://dx.doi.org/10.1128/JB.182.22.6308-6321.2000.
18. Wang Q, Zhao Y, McClelland M, Harshey RM. 2007. The RcsCDB signaling system and swarming motility in Salmonella enterica serovar Typhimurium: dual regulation of flagellar and SPI-2 virulence genes. J. Bacteriol. 189:8447-8457. http://dx.doi.org/10.1128/JB.01198-07.
19. Prouty AM, Schwesinger WH, Gunn JS. 2002. Biofilm formation and interaction with the surfaces of gallstones by Salmonella spp. Infect. Immun. 70:2640-2649. http://dx.doi.org/10.1128/IAI.70.5.2640-2649.2002.
20. Lockman HA, Curtiss R, III. 1990. Salmonella typhimurium mutants lacking flagella or motility remain virulent in BALB/c mice. Infect. Immun. 58:137-143.
21. Yang X, Thornburg T, Suo Z, Jun S, Robison A, Li J, Lim T, Cao L, Hoyt T, Avci R, Pascual DW. 2012. Flagella overexpression attenuates Salmonella pathogenesis. PLoS One 7:e46828. http://dx.doi.org/10.1371/journal.pone.0046828.
22. Toley BJ, Forbes NS. 2012. Motility is critical for effective distribution and accumulation of bacteria in tumor tissue. Integr. Biol. 4:165-176. http://dx.doi.org/10.1039/c2ib00091a.
23. Leschner S, Westphal K, Dietrich N, Viegas N, Jablonska J, Lyszkiewicz M, Lienenklaus S, Falk W, Gekara N, Loessner H, Weiss S. 2009. Tumor invasion of Salmonella enterica serovar. Typhimurium is accompanied by strong hemorrhage promoted by TNF-alpha. PLoS One 4:e6692. http://dx.doi.org/10.1371/journal.pone.0006692.
24. Upadhyay M, Samal J, Kandpal M, Singh OV, Vivekanandan P. 2013. The Warburg effect: insights from the past decade. Pharmacol. Ther. 137: 318-330. http://dx.doi.org/10.1016/j.pharmthera.2012.11.003.
25. Dang CV, Semenza GL. 1999. Oncogenic alterations of metabolism. Trends Biochem. Sci. 24:68-72. http://dx.doi.org/10.1016/S0968-0004(99)01470-X.
26. Leschner S, Deyneko IV, Lienenklaus S, Wolf K, Bloecker H, Bumann D, Loessner H, Weiss S. 2012. Identification of tumor-specific Salmonella typhimurium promoters and their regulatory logic. Nucleic Acids Res. 40:2984-2994. http://dx.doi.org/10.1093/nar/gkr1041.
27. Izuishi K, Kato K, Ogura T, Kinoshita T, Esumi H. 2000. Remarkable tolerance of tumor cells to nutrient deprivation: possible new biochemical target for cancer therapy. Cancer Res. 60:6201-6207.
28. Gingrich JR, Barrios RJ, Morton RA, Boyce BF, DeMayo FJ, Finegold MJ, Angelopoulou R, Rosen JM, Greenberg NM. 1996. Metastatic prostate cancer in a transgenic mouse. Cancer Res. 56:4096-4102.
29. McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, Courtney L, Porwollik S, Ali J, Dante M, Du F, Hou S, Layman D, Leonard S, Nguyen C, Scott K, Holmes A, Grewal N, Mulvaney E, Ryan E, Sun H, Florea L, Miller W, Stoneking T, Nhan M, Waterston R, Wilson RK. 2001. Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 413:852-856. http://dx.doi.org/10.1038/35101614.
30. Sutton A, Buencamino R, Eisenstark A. 2000. rpoS mutants in archival cultures of Salmonella enterica serovar typhimurium. J. Bacteriol. 182: 4375-4379. http://dx.doi.org/10.1128/JB.182.16.4375-4379.2000.
31. Gunderson CW, Boldt JL, Authement RN, Segall AM. 2009. Peptide wrwycr inhibits the excision of several prophages and traps Holliday junctions inside bacteria. J. Bacteriol. 191:2169-2176. http://dx.doi.org/10.1128/JB.01559-08.
32. Kropinski AM, Sulakvelidze A, Konczy P, Poppe C. 2007. Salmonella phages and prophages—genomics and practical aspects. Methods Mol. Biol. 394:133-175. http://dx.doi.org/10.1007/978-1-59745-512-1_9.
33. Lilleengen K. 1950. Typing of Salmonella dublin and Salmonella enteritidis by means of bacteriophage. Acta Pathol. Microbiol. Scand. 27: 625-640.